Drawing for DEMTEGE

USPTO serial 97896225

DEMTEGE

Reviewed by CopyMark Law Group

Status 734Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
NKOJO, RHODA K
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 734: Status 734 means the fifth and typically final extension to file a Statement of Use was granted. You must file an acceptable Statement of Use before this last extension expires or the application will abandon.

Need help with DEMTEGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $150

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lori Wolfe

Lori Wolfe Teva Pharmaceuticals USA, Inc.400 Interpace ParkwayBuilding AParsippany, NJ 07054

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications. Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 19, 2026EX5GSOU EXTENSION 5 GRANTED—
Oct 2, 2026EXT5SOU EXTENSION 5 FILED—
Oct 2, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 5, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 4, 2026EX4GSOU EXTENSION 4 GRANTED—
Aug 3, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 4, 2026TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
May 4, 2026NREVNOTICE OF REVIVAL - E-MAILED—
May 4, 2026PETGPETITION TO REVIVE-GRANTED—
May 4, 2026PROATEAS PETITION TO REVIVE RECEIVED—
May 4, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 4, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 1, 2026EXT4SOU EXTENSION 4 FILED—
Mar 9, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 9, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2025EX3GSOU EXTENSION 3 GRANTED—
Sep 16, 2025EXT3SOU EXTENSION 3 FILED—
Sep 16, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 13, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 12, 2025EX2GSOU EXTENSION 2 GRANTED—
Mar 12, 2025EXT2SOU EXTENSION 2 FILED—
Mar 12, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 25, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 25, 2024EX1GSOU EXTENSION 1 GRANTED—
Sep 25, 2024EXT1SOU EXTENSION 1 FILED—
Sep 25, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 2, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 6, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 6, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 17, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 3, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 2, 2024DOCKASSIGNED TO EXAMINER—
May 15, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance